DISPERSYN GERRIT (Chief Development Officer) purchased 13.9% of their position (2K shares) of PHIO PHARMACEUTICALS CORP. on the open market
Open‑market purchase worth $5.0K — a moderate purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 8/19/2020ACC: 0001209191-20-047533
Officer· Chief Development Officer
Since Aug 2018
+2K
Net shares
Net buyer
$5.0K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
2K acquired
Non-Derivative Transactions1
Common stock, $0.0001 par value
Direct
Shares
+2K
Price / share
$2.50
Trade value
$5K
% of position
13.9%
8/19/2020
14.38K→16.38K
Total
Net shares
+2K
Net value
$5K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common stock, $0.0001 par value Direct | 8/19/2020 | P · Purchase | +2K | $2.50 | $5K | 13.9% | 14.38K | 16.38K |
| Total | +2K | $5K | ||||||
Derivative Transactions0
No derivative transactions reported